🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Stroke survivors get FDA-approved daily pill shown to cut repeat risk by 26%

Top Story • November 14, 2026 •
Stroke survivors get FDA-approved daily pill shown to cut repeat risk by 26%
Sunharbo (asundexian) is the first FDA-approved factor XIa inhibitor for secondary stroke prevention, but key limitations and risks do remain.
Source: FoxNews | https://feeds.feedburner.com/foxnews/latest - Read Original
"Adventure is where you chose to go."

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"We build AI or anything ICST"
"Output is a realization of Input."